Literature DB >> 30789634

Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors.

Sean T Massa1, Nosayaba Osazuwa-Peters2, Eric Adjei Boakye3,4, Ronald J Walker2, Gregory M Ward2.   

Abstract

IMPORTANCE: Head and neck cancer (HNC) is more common among socioeconomically disenfranchised individuals, making financial burden particularly relevant.
OBJECTIVE: To assess the financial burdens of HNC compared with other cancers. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective review of nationally representative, publicly available survey, data from the Medical Expenditure Panel Survey were extracted from January 1, 1998, to December 31, 2015. A total of 444 867 adults were surveyed, which extrapolates to a population of 221 503 108 based on the weighted survey design. Data analysis was performed from April 18, 2018, to August 20, 2018. EXPOSURES: Of 16 771 patients with cancer surveyed (weighted count of 10 083 586 patients), 489 reported HNC (weighted count of 261 631). MAIN OUTCOMES AND MEASURES: Patients with HNC were compared with patients with other cancers on demographics, income, employment, and health. Within the HNC group, risk factors for total medical expenses and relative out-of-pocket expenses were assessed with regression modeling. Complex sampling methods were accounted for with weighting using balanced repeated replication.
RESULTS: A total of 16 771 patients (mean [SD] age, 62.3 [18.9] years; 9006 [53.7%] female) with cancer were studied. Compared with patients with other cancers, patients with HNC were more often members of a minority race/ethnicity, male, poor, publicly insured, and less educated, with lower general and mental health status. Median annual medical expenses ($8384 vs $5978; difference, $2406; 95% CI, $795-$4017) and relative out-of-pocket expenses (3.93% vs 3.07%; difference, 0.86%; 95% CI, 0.06%-1.66%) were higher for patients with HNC than for patients with other cancers. Among patients with HNC, median expenses were lower for Asian individuals compared with white individuals ($5359 vs $10 078; difference, $4719; 95% CI, $1481-$7956]), Westerners ($8094) and Midwesterners ($5656) compared with Northwesterners ($10 549), and those with better health status ($16 990 for those with poor health vs $6714 for those with excellent health). Higher relative out-of-pocket expenses were associated with unemployment (5.13% for employed patients vs 2.35% for unemployed patients; difference, 2.78%; 95% CI, 0.6%-4.95%), public insurance (5.35% for those with public insurance vs 2.87% for those with private insurance; difference, 2.48%; 95% CI, -0.6% to 5.55%), poverty (13.07% for poor patients vs 2.06% for high-income patients), and lower health status (10.2% for those with poor health vs 1.58% for those with excellent health). CONCLUSIONS AND RELEVANCE: According to this study, HNC adds a substantial, additional burden to an already financially strained population in the form of higher total and relative expenses. The financial strain on individuals, assessed as relative out-of-pocket expenses, appears to be driven more by income than by health factors, and health insurance does not appear to be protective.

Entities:  

Mesh:

Year:  2019        PMID: 30789634      PMCID: PMC6439752          DOI: 10.1001/jamaoto.2018.3982

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  53 in total

Review 1.  Racial Disparity Among the Head and Neck Cancer Population.

Authors:  Pedram Daraei; Charles E Moore
Journal:  J Cancer Educ       Date:  2015-09       Impact factor: 2.037

2.  Racial disparities in medical expenditures within body weight categories.

Authors:  Sai Ma; Kevin D Frick; Sara Bleich; Lisa Dubay
Journal:  J Gen Intern Med       Date:  2012-01-26       Impact factor: 5.128

3.  Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.

Authors:  T Kim Le; Katherine B Winfree; Hongbo Yang; Maryna Marynchenko; Andrew P Yu; Christian Frois; Eric Q Wu
Journal:  J Med Econ       Date:  2012-04-20       Impact factor: 2.448

4.  Predictors of stage at presentation and outcomes of head and neck cancers in a university hospital setting.

Authors:  Nosayaba Osazuwa-Peters; Kara M Christopher; Adnan S Hussaini; Anit Behera; Ronald J Walker; Mark A Varvares
Journal:  Head Neck       Date:  2015-12-23       Impact factor: 3.147

5.  Health Insurance Affects Head and Neck Cancer Treatment Patterns and Outcomes.

Authors:  Gino Inverso; Brandon A Mahal; Ayal A Aizer; R Bruce Donoff; Sung-Kiang Chuang
Journal:  J Oral Maxillofac Surg       Date:  2016-01-08       Impact factor: 1.895

6.  Treatment delays, race, and outcomes in head and neck cancer.

Authors:  Arash O Naghavi; Michelle I Echevarria; Tobin J Strom; Yazan A Abuodeh; Kamran A Ahmed; Puja S Venkat; Andy Trotti; Louis B Harrison; B Lee Green; Kosj Yamoah; Jimmy J Caudell
Journal:  Cancer Epidemiol       Date:  2016-09-22       Impact factor: 2.984

7.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.

Authors:  S Yousuf Zafar; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy M Goetzinger; Xiaoyin Zhong; Amy P Abernethy
Journal:  Oncologist       Date:  2013-02-26

Review 8.  Systematic review of comorbidity indices for administrative data.

Authors:  Mansour T A Sharabiani; Paul Aylin; Alex Bottle
Journal:  Med Care       Date:  2012-12       Impact factor: 2.983

9.  Cost of care for early- and late-stage oral and pharyngeal cancer in the California Medicaid population.

Authors:  Joshua D Epstein; Tara K Knight; Joel B Epstein; Mark A Bride; Michael B Nichol
Journal:  Head Neck       Date:  2008-02       Impact factor: 3.147

10.  Neighborhood socioeconomic deprivation and mortality: NIH-AARP diet and health study.

Authors:  Jacqueline M Major; Chyke A Doubeni; Neal D Freedman; Yikyung Park; Min Lian; Albert R Hollenbeck; Arthur Schatzkin; Barry I Graubard; Rashmi Sinha
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

View more
  22 in total

1.  Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.

Authors:  Whitney H Beeler; Emily L Bellile; Keith A Casper; Elizabeth Jaworski; Nicholas J Burger; Kelly M Malloy; Matthew E Spector; Andrew G Shuman; Andrew Rosko; Chaz L Stucken; Steven B Chinn; Aleksandar F Dragovic; Christina H Chapman; Dawn Owen; Shruti Jolly; Carol R Bradford; Mark E P Prince; Francis P Worden; Reshma Jagsi; Michelle L Mierzwa; Paul L Swiecicki
Journal:  Oral Oncol       Date:  2019-12-23       Impact factor: 5.337

2.  Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.

Authors:  Silke Tribius; Sven Haladyn; Henning Hanken; Chia-Jung Busch; Andreas Krüll; Cordula Petersen; Corinna Bergelt
Journal:  Strahlenther Onkol       Date:  2020-12-30       Impact factor: 3.621

3.  European white paper: oropharyngeal dysphagia in head and neck cancer.

Authors:  Laura W J Baijens; Margaret Walshe; Leena-Maija Aaltonen; Christoph Arens; Reinie Cordier; Patrick Cras; Lise Crevier-Buchman; Chris Curtis; Wojciech Golusinski; Roganie Govender; Jesper Grau Eriksen; Kevin Hansen; Kate Heathcote; Markus M Hess; Sefik Hosal; Jens Peter Klussmann; C René Leemans; Denise MacCarthy; Beatrice Manduchi; Jean-Paul Marie; Reza Nouraei; Claire Parkes; Christina Pflug; Walmari Pilz; Julie Regan; Nathalie Rommel; Antonio Schindler; Annemie M W J Schols; Renee Speyer; Giovanni Succo; Irene Wessel; Anna C H Willemsen; Taner Yilmaz; Pere Clavé
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-12-19       Impact factor: 2.503

4.  Characterizing head and neck cancer survivors' discontinuation of survivorship care.

Authors:  Aaron T Seaman; Kristen L Seligman; Khanh K Nguyen; Zaid Al-Qurayshi; Nicholas D Kendell; Nitin A Pagedar
Journal:  Cancer       Date:  2021-08-30       Impact factor: 6.860

Review 5.  The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Authors:  Nicolas Iragorri; Claire de Oliveira; Natalie Fitzgerald; Beverley Essue
Journal:  Curr Oncol       Date:  2021-03-15       Impact factor: 3.677

Review 6.  Racial and Ethnic Disparities in Laryngeal Cancer Care.

Authors:  Steven R Cox; Carolann L Daniel
Journal:  J Racial Ethn Health Disparities       Date:  2021-03-17

7.  Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.

Authors:  Inseon Choi; Donghwan Lee; Kyung-Bok Son; SeungJin Bae
Journal:  BMC Public Health       Date:  2020-06-29       Impact factor: 3.295

8.  Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer.

Authors:  Grace L Smith; Shuangshuang Fu; Matthew S Ning; Diem-Khanh Nguyen; Paul M Busse; Robert L Foote; Adam S Garden; Gary B Gunn; Clifton D Fuller; William H Morrison; Gregory M Chronowski; Shalin J Shah; Lauren L Mayo; Jack Phan; Jay P Reddy; James W Snider; Samir H Patel; Sanford R Katz; Alexander Lin; Nasiruddin Mohammed; Roi Dagan; Nancy Y Lee; David I Rosenthal; Steven J Frank
Journal:  Int J Part Ther       Date:  2021-06-25

9.  Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma.

Authors:  Nicholas R Lenze; Douglas R Farquhar; Siddharth Sheth; Jose P Zevallos; Catherine Lumley; Jeffrey Blumberg; Samip Patel; Trevor Hackman; Mark C Weissler; Wendell G Yarbrough; Andrew F Olshan; Adam M Zanation
Journal:  Oral Oncol       Date:  2021-06-20       Impact factor: 5.972

10.  The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.

Authors:  Khalil Baddour; Mark Fadel; Meng Zhao; Michael Corcoran; Maryanna S Owoc; Teresa H Thomas; Lindsay M Sabik; Marci L Nilsen; Robert L Ferris; Leila J Mady
Journal:  Head Neck       Date:  2021-07-08       Impact factor: 3.821

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.